Global Live Attenuated Rotavirus Vaccine Market Growth 2026-2032
The global Live Attenuated Rotavirus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Rotavirus spreads easily among infants and young children. The virus can cause severe watery diarrhea, vomiting, fever, and abdominal pain. Children who get rotavirus disease can become dehydrated and may need to be hospitalized. Live attenuated rotavirus vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable.
United States market for Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Live Attenuated Rotavirus Vaccine players cover Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Live Attenuated Rotavirus Vaccine Industry Forecast? looks at past sales and reviews total world Live Attenuated Rotavirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Live Attenuated Rotavirus Vaccine sales for 2026 through 2032. With Live Attenuated Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Attenuated Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Live Attenuated Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Attenuated Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Attenuated Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Attenuated Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Attenuated Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Rotavirus spreads easily among infants and young children. The virus can cause severe watery diarrhea, vomiting, fever, and abdominal pain. Children who get rotavirus disease can become dehydrated and may need to be hospitalized. Live attenuated rotavirus vaccine is a vaccine created by reducing the virulence of a pathogen, but still keeping it viable.
United States market for Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Live Attenuated Rotavirus Vaccine is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Live Attenuated Rotavirus Vaccine players cover Merck Sharp & Dohme, GSK, Bharat Biotech, Lanzhou Biological Products Research Institute, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the ?Live Attenuated Rotavirus Vaccine Industry Forecast? looks at past sales and reviews total world Live Attenuated Rotavirus Vaccine sales in 2025, providing a comprehensive analysis by region and market sector of projected Live Attenuated Rotavirus Vaccine sales for 2026 through 2032. With Live Attenuated Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Live Attenuated Rotavirus Vaccine industry.
This Insight Report provides a comprehensive analysis of the global Live Attenuated Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Live Attenuated Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Live Attenuated Rotavirus Vaccine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Live Attenuated Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Live Attenuated Rotavirus Vaccine.
This report presents a comprehensive overview, market shares, and growth opportunities of Live Attenuated Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Monovalent Vaccines
- Combination Vaccines
- Hospitals and Clinics
- Vaccination Sites
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Merck Sharp & Dohme
- GSK
- Bharat Biotech
- Lanzhou Biological Products Research Institute
- What is the 10-year outlook for the global Live Attenuated Rotavirus Vaccine market?
- What factors are driving Live Attenuated Rotavirus Vaccine market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Live Attenuated Rotavirus Vaccine market opportunities vary by end market size?
- How does Live Attenuated Rotavirus Vaccine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Attenuated Rotavirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Live Attenuated Rotavirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Live Attenuated Rotavirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Live Attenuated Rotavirus Vaccine Segment by Type
2.2.1 Monovalent Vaccines
2.2.2 Combination Vaccines
2.2.3 Live Attenuated Rotavirus Vaccine Sales by Type
2.2.3.1 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Live Attenuated Rotavirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Live Attenuated Rotavirus Vaccine Sale Price by Type (2021-2026)
2.3 Live Attenuated Rotavirus Vaccine Segment by Application
2.3.1 Hospitals and Clinics
2.3.2 Vaccination Sites
2.3.3 Live Attenuated Rotavirus Vaccine Sales by Application
2.3.3.1 Global Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Live Attenuated Rotavirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Live Attenuated Rotavirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Live Attenuated Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Live Attenuated Rotavirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Live Attenuated Rotavirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Live Attenuated Rotavirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Live Attenuated Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Live Attenuated Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Attenuated Rotavirus Vaccine Product Location Distribution
3.4.2 Players Live Attenuated Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVE ATTENUATED ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Live Attenuated Rotavirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Live Attenuated Rotavirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Live Attenuated Rotavirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Live Attenuated Rotavirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Live Attenuated Rotavirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Live Attenuated Rotavirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Live Attenuated Rotavirus Vaccine Sales Growth
4.4 APAC Live Attenuated Rotavirus Vaccine Sales Growth
4.5 Europe Live Attenuated Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Live Attenuated Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Live Attenuated Rotavirus Vaccine Sales by Country
5.1.1 Americas Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Live Attenuated Rotavirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026)
5.3 Americas Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Attenuated Rotavirus Vaccine Sales by Region
6.1.1 APAC Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Live Attenuated Rotavirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026)
6.3 APAC Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Live Attenuated Rotavirus Vaccine by Country
7.1.1 Europe Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Live Attenuated Rotavirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026)
7.3 Europe Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Attenuated Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Live Attenuated Rotavirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Attenuated Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Live Attenuated Rotavirus Vaccine
10.4 Industry Chain Structure of Live Attenuated Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Attenuated Rotavirus Vaccine Distributors
11.3 Live Attenuated Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR LIVE ATTENUATED ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Live Attenuated Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Live Attenuated Rotavirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Live Attenuated Rotavirus Vaccine Forecast by Type (2027-2032)
12.7 Global Live Attenuated Rotavirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck Sharp & Dohme
13.1.1 Merck Sharp & Dohme Company Information
13.1.2 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Sharp & Dohme Main Business Overview
13.1.5 Merck Sharp & Dohme Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 GSK Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Bharat Biotech Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 Lanzhou Biological Products Research Institute
13.4.1 Lanzhou Biological Products Research Institute Company Information
13.4.2 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lanzhou Biological Products Research Institute Main Business Overview
13.4.5 Lanzhou Biological Products Research Institute Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Live Attenuated Rotavirus Vaccine Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Live Attenuated Rotavirus Vaccine by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Live Attenuated Rotavirus Vaccine by Country/Region, 2021, 2025 & 2032
2.2 Live Attenuated Rotavirus Vaccine Segment by Type
2.2.1 Monovalent Vaccines
2.2.2 Combination Vaccines
2.2.3 Live Attenuated Rotavirus Vaccine Sales by Type
2.2.3.1 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
2.2.3.2 Global Live Attenuated Rotavirus Vaccine Revenue and Market Share by Type (2021-2026)
2.2.3.3 Global Live Attenuated Rotavirus Vaccine Sale Price by Type (2021-2026)
2.3 Live Attenuated Rotavirus Vaccine Segment by Application
2.3.1 Hospitals and Clinics
2.3.2 Vaccination Sites
2.3.3 Live Attenuated Rotavirus Vaccine Sales by Application
2.3.3.1 Global Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2021-2026)
2.3.3.2 Global Live Attenuated Rotavirus Vaccine Revenue and Market Share by Application (2021-2026)
2.3.3.3 Global Live Attenuated Rotavirus Vaccine Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Live Attenuated Rotavirus Vaccine Breakdown Data by Company
3.1.1 Global Live Attenuated Rotavirus Vaccine Annual Sales by Company (2021-2026)
3.1.2 Global Live Attenuated Rotavirus Vaccine Sales Market Share by Company (2021-2026)
3.2 Global Live Attenuated Rotavirus Vaccine Annual Revenue by Company (2021-2026)
3.2.1 Global Live Attenuated Rotavirus Vaccine Revenue by Company (2021-2026)
3.2.2 Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
3.3 Global Live Attenuated Rotavirus Vaccine Sale Price by Company
3.4 Key Manufacturers Live Attenuated Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Live Attenuated Rotavirus Vaccine Product Location Distribution
3.4.2 Players Live Attenuated Rotavirus Vaccine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR LIVE ATTENUATED ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
4.1 World Historic Live Attenuated Rotavirus Vaccine Market Size by Geographic Region (2021-2026)
4.1.1 Global Live Attenuated Rotavirus Vaccine Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Live Attenuated Rotavirus Vaccine Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Live Attenuated Rotavirus Vaccine Market Size by Country/Region (2021-2026)
4.2.1 Global Live Attenuated Rotavirus Vaccine Annual Sales by Country/Region (2021-2026)
4.2.2 Global Live Attenuated Rotavirus Vaccine Annual Revenue by Country/Region (2021-2026)
4.3 Americas Live Attenuated Rotavirus Vaccine Sales Growth
4.4 APAC Live Attenuated Rotavirus Vaccine Sales Growth
4.5 Europe Live Attenuated Rotavirus Vaccine Sales Growth
4.6 Middle East & Africa Live Attenuated Rotavirus Vaccine Sales Growth
5 AMERICAS
5.1 Americas Live Attenuated Rotavirus Vaccine Sales by Country
5.1.1 Americas Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
5.1.2 Americas Live Attenuated Rotavirus Vaccine Revenue by Country (2021-2026)
5.2 Americas Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026)
5.3 Americas Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Live Attenuated Rotavirus Vaccine Sales by Region
6.1.1 APAC Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026)
6.1.2 APAC Live Attenuated Rotavirus Vaccine Revenue by Region (2021-2026)
6.2 APAC Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026)
6.3 APAC Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Live Attenuated Rotavirus Vaccine by Country
7.1.1 Europe Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
7.1.2 Europe Live Attenuated Rotavirus Vaccine Revenue by Country (2021-2026)
7.2 Europe Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026)
7.3 Europe Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Live Attenuated Rotavirus Vaccine by Country
8.1.1 Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026)
8.1.2 Middle East & Africa Live Attenuated Rotavirus Vaccine Revenue by Country (2021-2026)
8.2 Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026)
8.3 Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Live Attenuated Rotavirus Vaccine
10.3 Manufacturing Process Analysis of Live Attenuated Rotavirus Vaccine
10.4 Industry Chain Structure of Live Attenuated Rotavirus Vaccine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Live Attenuated Rotavirus Vaccine Distributors
11.3 Live Attenuated Rotavirus Vaccine Customer
12 WORLD FORECAST REVIEW FOR LIVE ATTENUATED ROTAVIRUS VACCINE BY GEOGRAPHIC REGION
12.1 Global Live Attenuated Rotavirus Vaccine Market Size Forecast by Region
12.1.1 Global Live Attenuated Rotavirus Vaccine Forecast by Region (2027-2032)
12.1.2 Global Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Live Attenuated Rotavirus Vaccine Forecast by Type (2027-2032)
12.7 Global Live Attenuated Rotavirus Vaccine Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Merck Sharp & Dohme
13.1.1 Merck Sharp & Dohme Company Information
13.1.2 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.1.3 Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Merck Sharp & Dohme Main Business Overview
13.1.5 Merck Sharp & Dohme Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.2.3 GSK Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 Bharat Biotech
13.3.1 Bharat Biotech Company Information
13.3.2 Bharat Biotech Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.3.3 Bharat Biotech Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Bharat Biotech Main Business Overview
13.3.5 Bharat Biotech Latest Developments
13.4 Lanzhou Biological Products Research Institute
13.4.1 Lanzhou Biological Products Research Institute Company Information
13.4.2 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
13.4.3 Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Lanzhou Biological Products Research Institute Main Business Overview
13.4.5 Lanzhou Biological Products Research Institute Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Live Attenuated Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Live Attenuated Rotavirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monovalent Vaccines
Table 4. Major Players of Combination Vaccines
Table 5. Global Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Dose)
Table 6. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Live Attenuated Rotavirus Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Live Attenuated Rotavirus Vaccine Sale by Application (2021-2026) & (K Dose)
Table 11. Global Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Live Attenuated Rotavirus Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Live Attenuated Rotavirus Vaccine Sales by Company (2021-2026) & (K Dose)
Table 16. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Live Attenuated Rotavirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Live Attenuated Rotavirus Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Live Attenuated Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Live Attenuated Rotavirus Vaccine Products Offered
Table 22. Live Attenuated Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Live Attenuated Rotavirus Vaccine Sales by Geographic Region (2021-2026) & (K Dose)
Table 26. Global Live Attenuated Rotavirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Live Attenuated Rotavirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Live Attenuated Rotavirus Vaccine Sales by Country/Region (2021-2026) & (K Dose)
Table 30. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Live Attenuated Rotavirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Dose)
Table 34. Americas Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Live Attenuated Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Dose)
Table 37. Americas Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Dose)
Table 38. APAC Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026) & (K Dose)
Table 39. APAC Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Live Attenuated Rotavirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Dose)
Table 42. APAC Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Dose)
Table 43. Europe Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Dose)
Table 44. Europe Live Attenuated Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Dose)
Table 46. Europe Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Dose)
Table 47. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Dose)
Table 48. Middle East & Africa Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Dose)
Table 50. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Live Attenuated Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Live Attenuated Rotavirus Vaccine
Table 53. Key Industry Trends of Live Attenuated Rotavirus Vaccine
Table 54. Live Attenuated Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Live Attenuated Rotavirus Vaccine Distributors List
Table 57. Live Attenuated Rotavirus Vaccine Customer List
Table 58. Global Live Attenuated Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 59. Global Live Attenuated Rotavirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 61. Americas Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Live Attenuated Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 63. APAC Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 65. Europe Live Attenuated Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 67. Middle East & Africa Live Attenuated Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Live Attenuated Rotavirus Vaccine Sales Forecast by Type (2027-2032) & (K Dose)
Table 69. Global Live Attenuated Rotavirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Live Attenuated Rotavirus Vaccine Sales Forecast by Application (2027-2032) & (K Dose)
Table 71. Global Live Attenuated Rotavirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Sharp & Dohme Basic Information, Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. Merck Sharp & Dohme Main Business
Table 76. Merck Sharp & Dohme Latest Developments
Table 77. GSK Basic Information, Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 79. GSK Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Bharat Biotech Basic Information, Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Bharat Biotech Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 84. Bharat Biotech Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Bharat Biotech Main Business
Table 86. Bharat Biotech Latest Developments
Table 87. Lanzhou Biological Products Research Institute Basic Information, Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 89. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Lanzhou Biological Products Research Institute Main Business
Table 91. Lanzhou Biological Products Research Institute Latest Developments
Table 1. Live Attenuated Rotavirus Vaccine Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Live Attenuated Rotavirus Vaccine Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Monovalent Vaccines
Table 4. Major Players of Combination Vaccines
Table 5. Global Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Dose)
Table 6. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Table 7. Global Live Attenuated Rotavirus Vaccine Revenue by Type (2021-2026) & ($ million)
Table 8. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Table 9. Global Live Attenuated Rotavirus Vaccine Sale Price by Type (2021-2026) & (US$/Dose)
Table 10. Global Live Attenuated Rotavirus Vaccine Sale by Application (2021-2026) & (K Dose)
Table 11. Global Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2021-2026)
Table 12. Global Live Attenuated Rotavirus Vaccine Revenue by Application (2021-2026) & ($ million)
Table 13. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application (2021-2026)
Table 14. Global Live Attenuated Rotavirus Vaccine Sale Price by Application (2021-2026) & (US$/Dose)
Table 15. Global Live Attenuated Rotavirus Vaccine Sales by Company (2021-2026) & (K Dose)
Table 16. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Company (2021-2026)
Table 17. Global Live Attenuated Rotavirus Vaccine Revenue by Company (2021-2026) & ($ millions)
Table 18. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Company (2021-2026)
Table 19. Global Live Attenuated Rotavirus Vaccine Sale Price by Company (2021-2026) & (US$/Dose)
Table 20. Key Manufacturers Live Attenuated Rotavirus Vaccine Producing Area Distribution and Sales Area
Table 21. Players Live Attenuated Rotavirus Vaccine Products Offered
Table 22. Live Attenuated Rotavirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Live Attenuated Rotavirus Vaccine Sales by Geographic Region (2021-2026) & (K Dose)
Table 26. Global Live Attenuated Rotavirus Vaccine Sales Market Share Geographic Region (2021-2026)
Table 27. Global Live Attenuated Rotavirus Vaccine Revenue by Geographic Region (2021-2026) & ($ millions)
Table 28. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Geographic Region (2021-2026)
Table 29. Global Live Attenuated Rotavirus Vaccine Sales by Country/Region (2021-2026) & (K Dose)
Table 30. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2021-2026)
Table 31. Global Live Attenuated Rotavirus Vaccine Revenue by Country/Region (2021-2026) & ($ millions)
Table 32. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Country/Region (2021-2026)
Table 33. Americas Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Dose)
Table 34. Americas Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Table 35. Americas Live Attenuated Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 36. Americas Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Dose)
Table 37. Americas Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Dose)
Table 38. APAC Live Attenuated Rotavirus Vaccine Sales by Region (2021-2026) & (K Dose)
Table 39. APAC Live Attenuated Rotavirus Vaccine Sales Market Share by Region (2021-2026)
Table 40. APAC Live Attenuated Rotavirus Vaccine Revenue by Region (2021-2026) & ($ millions)
Table 41. APAC Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Dose)
Table 42. APAC Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Dose)
Table 43. Europe Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Dose)
Table 44. Europe Live Attenuated Rotavirus Vaccine Revenue by Country (2021-2026) & ($ millions)
Table 45. Europe Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Dose)
Table 46. Europe Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Dose)
Table 47. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Country (2021-2026) & (K Dose)
Table 48. Middle East & Africa Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Table 49. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Type (2021-2026) & (K Dose)
Table 50. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales by Application (2021-2026) & (K Dose)
Table 51. Key Market Drivers & Growth Opportunities of Live Attenuated Rotavirus Vaccine
Table 52. Key Market Challenges & Risks of Live Attenuated Rotavirus Vaccine
Table 53. Key Industry Trends of Live Attenuated Rotavirus Vaccine
Table 54. Live Attenuated Rotavirus Vaccine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Live Attenuated Rotavirus Vaccine Distributors List
Table 57. Live Attenuated Rotavirus Vaccine Customer List
Table 58. Global Live Attenuated Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 59. Global Live Attenuated Rotavirus Vaccine Revenue Forecast by Region (2027-2032) & ($ millions)
Table 60. Americas Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 61. Americas Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 62. APAC Live Attenuated Rotavirus Vaccine Sales Forecast by Region (2027-2032) & (K Dose)
Table 63. APAC Live Attenuated Rotavirus Vaccine Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 64. Europe Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 65. Europe Live Attenuated Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 66. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales Forecast by Country (2027-2032) & (K Dose)
Table 67. Middle East & Africa Live Attenuated Rotavirus Vaccine Revenue Forecast by Country (2027-2032) & ($ millions)
Table 68. Global Live Attenuated Rotavirus Vaccine Sales Forecast by Type (2027-2032) & (K Dose)
Table 69. Global Live Attenuated Rotavirus Vaccine Revenue Forecast by Type (2027-2032) & ($ millions)
Table 70. Global Live Attenuated Rotavirus Vaccine Sales Forecast by Application (2027-2032) & (K Dose)
Table 71. Global Live Attenuated Rotavirus Vaccine Revenue Forecast by Application (2027-2032) & ($ millions)
Table 72. Merck Sharp & Dohme Basic Information, Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 73. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 74. Merck Sharp & Dohme Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 75. Merck Sharp & Dohme Main Business
Table 76. Merck Sharp & Dohme Latest Developments
Table 77. GSK Basic Information, Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 78. GSK Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 79. GSK Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 80. GSK Main Business
Table 81. GSK Latest Developments
Table 82. Bharat Biotech Basic Information, Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 83. Bharat Biotech Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 84. Bharat Biotech Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 85. Bharat Biotech Main Business
Table 86. Bharat Biotech Latest Developments
Table 87. Lanzhou Biological Products Research Institute Basic Information, Live Attenuated Rotavirus Vaccine Manufacturing Base, Sales Area and Its Competitors
Table 88. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Product Portfolios and Specifications
Table 89. Lanzhou Biological Products Research Institute Live Attenuated Rotavirus Vaccine Sales (K Dose), Revenue ($ Million), Price (US$/Dose) and Gross Margin (2021-2026)
Table 90. Lanzhou Biological Products Research Institute Main Business
Table 91. Lanzhou Biological Products Research Institute Latest Developments
LIST OF FIGURES
Figure 1. Picture of Live Attenuated Rotavirus Vaccine
Figure 2. Live Attenuated Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Attenuated Rotavirus Vaccine Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Live Attenuated Rotavirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Live Attenuated Rotavirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monovalent Vaccines
Figure 12. Product Picture of Combination Vaccines
Figure 13. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type in 2026
Figure 14. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Live Attenuated Rotavirus Vaccine Consumed in Hospitals and Clinics
Figure 16. Global Live Attenuated Rotavirus Vaccine Market: Hospitals and Clinics (2021-2026) & (K Dose)
Figure 17. Live Attenuated Rotavirus Vaccine Consumed in Vaccination Sites
Figure 18. Global Live Attenuated Rotavirus Vaccine Market: Vaccination Sites (2021-2026) & (K Dose)
Figure 19. Global Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2025)
Figure 20. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application in 2026
Figure 21. Live Attenuated Rotavirus Vaccine Sales by Company in 2026 (K Dose)
Figure 22. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Company in 2026
Figure 23. Live Attenuated Rotavirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Live Attenuated Rotavirus Vaccine Sales 2021-2026 (K Dose)
Figure 28. Americas Live Attenuated Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Live Attenuated Rotavirus Vaccine Sales 2021-2026 (K Dose)
Figure 30. APAC Live Attenuated Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Live Attenuated Rotavirus Vaccine Sales 2021-2026 (K Dose)
Figure 32. Europe Live Attenuated Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales 2021-2026 (K Dose)
Figure 34. Middle East & Africa Live Attenuated Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Live Attenuated Rotavirus Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Live Attenuated Rotavirus Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Live Attenuated Rotavirus Vaccine
Figure 73. Industry Chain Structure of Live Attenuated Rotavirus Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Live Attenuated Rotavirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Live Attenuated Rotavirus Vaccine
Figure 2. Live Attenuated Rotavirus Vaccine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Live Attenuated Rotavirus Vaccine Sales Growth Rate 2021-2032 (K Dose)
Figure 7. Global Live Attenuated Rotavirus Vaccine Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Live Attenuated Rotavirus Vaccine Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2025)
Figure 10. Live Attenuated Rotavirus Vaccine Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Monovalent Vaccines
Figure 12. Product Picture of Combination Vaccines
Figure 13. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Type in 2026
Figure 14. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Type (2021-2026)
Figure 15. Live Attenuated Rotavirus Vaccine Consumed in Hospitals and Clinics
Figure 16. Global Live Attenuated Rotavirus Vaccine Market: Hospitals and Clinics (2021-2026) & (K Dose)
Figure 17. Live Attenuated Rotavirus Vaccine Consumed in Vaccination Sites
Figure 18. Global Live Attenuated Rotavirus Vaccine Market: Vaccination Sites (2021-2026) & (K Dose)
Figure 19. Global Live Attenuated Rotavirus Vaccine Sale Market Share by Application (2025)
Figure 20. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Application in 2026
Figure 21. Live Attenuated Rotavirus Vaccine Sales by Company in 2026 (K Dose)
Figure 22. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Company in 2026
Figure 23. Live Attenuated Rotavirus Vaccine Revenue by Company in 2026 ($ millions)
Figure 24. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Company in 2026
Figure 25. Global Live Attenuated Rotavirus Vaccine Sales Market Share by Geographic Region (2021-2026)
Figure 26. Global Live Attenuated Rotavirus Vaccine Revenue Market Share by Geographic Region in 2026
Figure 27. Americas Live Attenuated Rotavirus Vaccine Sales 2021-2026 (K Dose)
Figure 28. Americas Live Attenuated Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 29. APAC Live Attenuated Rotavirus Vaccine Sales 2021-2026 (K Dose)
Figure 30. APAC Live Attenuated Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 31. Europe Live Attenuated Rotavirus Vaccine Sales 2021-2026 (K Dose)
Figure 32. Europe Live Attenuated Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 33. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales 2021-2026 (K Dose)
Figure 34. Middle East & Africa Live Attenuated Rotavirus Vaccine Revenue 2021-2026 ($ millions)
Figure 35. Americas Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 36. Americas Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 37. Americas Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 38. Americas Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 39. United States Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 40. Canada Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 41. Mexico Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 42. Brazil Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 43. APAC Live Attenuated Rotavirus Vaccine Sales Market Share by Region in 2026
Figure 44. APAC Live Attenuated Rotavirus Vaccine Revenue Market Share by Region (2021-2026)
Figure 45. APAC Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 46. APAC Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 47. China Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 48. Japan Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 49. South Korea Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 50. Southeast Asia Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 51. India Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 52. Australia Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 53. China Taiwan Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 54. Europe Live Attenuated Rotavirus Vaccine Sales Market Share by Country in 2026
Figure 55. Europe Live Attenuated Rotavirus Vaccine Revenue Market Share by Country (2021-2026)
Figure 56. Europe Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 57. Europe Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 58. Germany Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 59. France Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 60. UK Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 61. Italy Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 62. Russia Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 63. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales Market Share by Country (2021-2026)
Figure 64. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales Market Share by Type (2021-2026)
Figure 65. Middle East & Africa Live Attenuated Rotavirus Vaccine Sales Market Share by Application (2021-2026)
Figure 66. Egypt Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 67. South Africa Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 68. Israel Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 69. Turkey Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 70. GCC Countries Live Attenuated Rotavirus Vaccine Revenue Growth 2021-2026 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Live Attenuated Rotavirus Vaccine in 2026
Figure 72. Manufacturing Process Analysis of Live Attenuated Rotavirus Vaccine
Figure 73. Industry Chain Structure of Live Attenuated Rotavirus Vaccine
Figure 74. Channels of Distribution
Figure 75. Global Live Attenuated Rotavirus Vaccine Sales Market Forecast by Region (2027-2032)
Figure 76. Global Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Region (2027-2032)
Figure 77. Global Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Type (2027-2032)
Figure 78. Global Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Type (2027-2032)
Figure 79. Global Live Attenuated Rotavirus Vaccine Sales Market Share Forecast by Application (2027-2032)
Figure 80. Global Live Attenuated Rotavirus Vaccine Revenue Market Share Forecast by Application (2027-2032)
